ArticleBiochemical genetics2026
LMNB2 Regulates Esophageal Carcinoma Stemness and Warburg Effect by Modulating the p38 MAPK Signaling Pathway.
Article in Biochemical genetics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Integrated bioinformatics and tissue-based validation reveal the oncogenic role of hsa_circ_0043256 and hsa_circ_0004789 in gastric cancer.Biochemistry and biophysics reports · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Esophageal carcinoma (ESCA) represents a highly aggressive malignancy with limited therapeutic options. Mounting evidence indicated that Nuclear Lamin B2 (LMNB2) was involved in tumor progression through modulation of multiple signaling pathways. However, the investigation of LMNB2 role in tumor cell stemness and the Warburg effect remains inconclusive. This study utilized the UALCAN database to perform pan-cancer, clinical sample and cell line analyses. Western blot validation demonstrated substantial LMNB2 overexpression in ESCA cells. Silencing LMNB2 expression significantly repressed ESCA cells stemness and Warburg effect. Integrated bioinformatics analyses using Linkedomics, Funrich, and String databases identified the p38 MAPK pathway as a downstream mediator. In vitro experiments verified the regulatory impact of LMNB2 on the p38 phosphorylation in the MAPK signaling pathway, implicated in the regulation of tumor sphere formation and the Warburg effect. LMNB2 also exhibited a regulatory role in tumor growth within the mouse xenograft model. This study proposed that LMNB2 could emerge as a novel therapeutic strategy for treating ESCA.
Indexed as
Identifiers
41236686What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.